AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Rega, S Stiewe, T Chang, DI Pollmeier, B Esche, H Bardenheuer, W Marquitan, G Putzer, BM
Citation: S. Rega et al., Identification of the full-length huntingtin-interacting protein p231HBP/HYPB as a DNA-binding factor, MOL CELL NE, 18(1), 2001, pp. 68-79

Authors: Brockmann, D Lehmkuhler, O Schmucker, U Esche, H
Citation: D. Brockmann et al., The histone acetyltransferase activity of PCAF cooperates with the brahma/SW12-related protein BRG-1 in the activation of the enhancer A of the MHC class I promoter, GENE, 277(1-2), 2001, pp. 111-120

Authors: Fax, P Carlson, CR Collas, P Tasken, K Esche, H Brockmann, D
Citation: P. Fax et al., Binding of PKA-RII alpha to the adenovirus E1A(12S) oncoprotein correlateswith its nuclear translocation and an increase in PKA-dependent promoter activity, VIROLOGY, 285(1), 2001, pp. 30-41

Authors: Putzer, BM Stiewe, T Parssanedjad, K Rega, S Esche, H
Citation: Bm. Putzer et al., E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products, CELL DEAT D, 7(2), 2000, pp. 177-188

Authors: Putzer, BM Stiewe, T Crespo, F Esche, H
Citation: Bm. Putzer et al., Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy, GENE THER, 7(15), 2000, pp. 1317-1325

Authors: Dickopp, A Esche, H Swart, G Seeber, S Kirch, HC Opalka, B
Citation: A. Dickopp et al., Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells, CANC GENE T, 7(7), 2000, pp. 1043-1050

Authors: Fax, P Lehmkuhler, O Kuhn, C Esche, H Brockmann, D
Citation: P. Fax et al., E1A(12S)-mediated activation of the adenovirus type 12 E2 promoter dependson the histone acetyltransferase activity of p300/CBP, J BIOL CHEM, 275(51), 2000, pp. 40554-40560

Authors: Fax, P Lipinski, KS Esche, H Brockmann, D
Citation: P. Fax et al., CAMP-independent activation of the adenovirus type 12 E2 promoter correlates with the recruitment of CREB-1/ATF-1, E1A(12S), and CBP to the E2-CRE, J BIOL CHEM, 275(12), 2000, pp. 8911-8920

Authors: Stiewe, T Parssanedjad, K Esche, H Opalka, B Putzer, BM
Citation: T. Stiewe et al., E1A overcomes the apoptosis block in BCR-ABL plus leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents, CANCER RES, 60(14), 2000, pp. 3957-3964

Authors: Kirch, HC Flaswinkel, S Rumpf, H Brockmann, D Esche, H
Citation: Hc. Kirch et al., Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappa B and Myc/Max, ONCOGENE, 18(17), 1999, pp. 2728-2738

Authors: Rumpf, H Esche, H Kirch, HC
Citation: H. Rumpf et al., Two domains within the adenovirus type 12 E1A unique spacer have disparateeffects on the interaction of E1A with p105-Rb and the transformation of primary mouse cells, VIROLOGY, 257(1), 1999, pp. 45-53

Authors: Lipinski, KS Fax, P Wilker, B Hennemann, H Brockmann, D Esche, H
Citation: Ks. Lipinski et al., Differences in the interactions of oncogenic adenovirus 12 early region 1Aand nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP, VIROLOGY, 255(1), 1999, pp. 94-105
Risultati: 1-12 |